SWOT Analysis for Infinium Pharmachem Ltd.

Add SWOT widget to your site/app

Companies with no Debt
Price crossing above SMA20 today, and greater than SMA5
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Week
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter

Companies with no Debt

Price crossing above SMA20 today, and greater than SMA5

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Week

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Declining profitability: Falling ROCE

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Declining profitability: Falling ROCE

Buys by Superstar Investors

Buys by Superstar Investors

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Infinium Pharmachem Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Infinium Pharmachem Ltd. has 9 Strengths, 10 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Companies with no Debt

Price crossing above SMA20 today, and greater than SMA5

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Week

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Declining profitability: Falling ROCE

Buys by Superstar Investors

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks